Biogen Inc Tysabri In Trouble? Jefferies Weighs In

compared to the stock’s closing price of $298.34 on Wednesday, September 23. Biogen’s stock performance, if analyzed for the year so far, has been much below the market. The drug maker’s stock has lost 13.67% YTD, performing below the NASDAQ … http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=95DD46800D2740C1BD1CBC74EAAB10E2&url=http%3a%2f%2fwww.bidnessetc.com%2f53537-biogen-inc-tysabri-in-trouble-jefferies-weighs-in%2f&c=RmDW2WuhRRv8IwuH_P_GJ2qbQ_Wn3Ts5B49DHpd5XuY&mkt=en-us